Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-02

FDA Approved: RISPERIDONE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin Pharmaceuticals' generic risperidone through an Original Application for use in established indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

ORIG AP for RISPERIDONE (RISPERIDONE)